‘Gamechanger’ brought in after success of trial offering larger doses of drugs within first two weeks of treatment
People in Britain with heart failure are being given larger doses of drugs at the start of their treatment after a global study found that this led to a huge fall in deaths.
Experts say the new approach could mean those with the potentially fatal condition start receiving their ideal amount of medication within two weeks of diagnosis rather than after many months.
More Stories
‘A slippery slope to eugenics’: advocates reject RFK Jr’s national autism database
Scientists record seismic tremors from title-clinching Liverpool win over Spurs
Elon Musk’s company town: SpaceX employees vote to create ‘Starbase’